Cometriq is a drug that interferes with cancer cell growth. It is indicated for the treatment of patients that are suffering from progressive metastatic medullary thyroid cancer (MTC). This medication slows down and stops the growth of cancer cells in the body. It belongs to a drug class that is known as tyrosine kinase inhibitors.
Drug Name: Cometriq
Generic name: Cabozantinib